Scolaris Content Display Scolaris Content Display

Intermittent pneumatic compression for critical limb ischaemia

References

Additional references

Adam 2005

Adam DJ, Beard JD, Cleveland T, Bell J, Bradbury AW, Forbes JF, et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet 2005;366(9501):1925‐34.

Atkins 2004

Atkins D, Best D, Briss PA, Eccles M, Falck‐Ytter Y, Flottorp S, et al. Grading quality of evidence and strength of recommendations. British Medical Journal 2004;328(7454):1490‐4.

Dai 2002

Dai G, Tsukurov O, Chen M, Gertler JP, Kamm RD. Endothelial nitric oxide production during in vitro simulation of external limb compression. American Journal of Physiology. Heart and Circulatory Physiology 2002;282(6):H2066‐75. [PUBMED: 12003813]

Delis 2005

Delis KT, Nicolaides AN. Effect of intermittent pneumatic compression of foot and calf on walking distance, hemodynamics, and quality of life in patients with arterial claudication: a prospective randomized controlled study with 1‐year follow‐up. Annals of Surgery 2005;241(3):431‐41. [PUBMED: 15729065]

Dillon 1986

Dillon RS. Successful treatment of osteomyelitis and soft tissue infections in ischemic diabetic legs by local antibiotic injections and the end‐diastolic pneumatic compression boot. Annals of Surgery 1986;204(6):643‐9.

Dua 2016

Dua A, Lee CJ. Epidemiology of peripheral arterial disease and critical limb ischemia. Techniques in Vascular and Interventional Radiology 2016;19(2):91‐5. [PUBMED: 27423989]

Fontaine 1954

Fontaine R, Kim M, Kieny R. Surgical treatment of peripheral circulation disorders [Die chirurgische Behandlung der peripheren Durchblutungsstorungen]. Helvetica Chirurgica Acta 1954;21(5‐6):499‐533. [PUBMED: 14366554]

Guyatt 2008

Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck‐Ytter Y, Alonso‐Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. British Medical Journal 2008;336(7650):924‐6. [PUBMED: 18436948]

Henriksen 1974

Henriksen O. Orthostatic changes of blood flow in subcutaneous tissue in patients with arterial insufficiency of the legs. Scandinavian Journal of Clinical and Laboratory Investigation 1974;34(2):103‐9. [PUBMED: 4423224]

Hiatt 2001

Hiatt WR. Medical treatment of peripheral arterial disease and claudication. New England Journal of Medicine 2001;344(21):1608‐21. [PUBMED: 11372014]

Higgins 2011

Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.

Labropoulos 2005

Labropoulos N, Leon LR, Bhatti A, Melton S, Kang SS, Mansour AM, et al. Hemodynamic effects of intermittent pneumatic compression in patients with critical limb ischemia. Journal of Vascular Surgery 2005;42(4):710‐6. [PUBMED: 16242559]

Liberati 2009

Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, et al. The PRISMA statement for reporting systematic reviews and meta‐analyses of studies that evaluate health care interventions: explanation and elaboration. PLOS Medicine 2009;6(7):e1000100.

Matsumoto 2016

Matsumoto T, Tanaka M, Yoshiya K, Yoshiga R, Matsubara Y, Horiuchi‐Yoshida K, et al. Improved quality of life in patients with no‐option critical limb ischemia undergoing gene therapy with DVC1‐0101. Scientific Reports 2016;6:30035. [PUBMED: 27418463]

McDermott 2001

McDermott MM, Greenland P, Liu K, Guralnik JM, Criqui MH, Dolan NC, et al. Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment. Journal of the American Medical Association 2001;286(13):1599‐606. [PUBMED: 11585483]

Moran 2015

Moran PS, Teljeur C, Harrington P, Ryan M. A systematic review of intermittent pneumatic compression for critical limb ischaemia. Vascular Medicine 2015;20(1):41‐50. [PUBMED: 25270409]

Norgren 2007

Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FGR. Inter‐Society Consensus for the Management of Peripheral Arterial Disease (TASC II). TASC II 2007;45(1):S5‐S67.

Parmar 1998

Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta‐analyses of the published literature for survival endpoints. Statistics in Medicine 1998;17(24):2815‐34. [PUBMED: 9921604]

Pawlaczyk 2015

Pawlaczyk K, Gabriel M, Urbanek T, Dzieciuchowicz Ł, Krasiński Z, Gabriel Z, et al. Effects of intermittent pneumatic compression on reduction of postoperative lower extremity edema and normalization of foot microcirculation flow in patients undergoing arterial revascularization. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research 2015;21:3986‐92.

Peach 2012

Peach G, Griffin M, Jones KG, Thompson MM, Hinchliffe RJ. Diagnosis and management of peripheral arterial disease. British Medical Journal 2012;345:e5208. [PUBMED: 22893640]

Prause 1998

Prause G, Ratzenhofer‐Komenda B, Smolle‐Juettner F, Krenn H, Pojer H, Toller W, et al. Operations on patients deemed "unfit for operation and anaesthesia": what are the consequences?. Acta Anaesthesiologica Scandinavica 1998;42(3):316‐22. [PUBMED: 9542559]

Reinecke 2015

Reinecke H, Unrath M, Freisinger E, Bunzemeier H, Meyborg M, Luders F, et al. Peripheral arterial disease and critical limb ischaemia: still poor outcomes and lack of guideline adherence. European Heart Journal 2015;36(15):932‐8. [PUBMED: 25650396]

RevMan 2014 [Computer program]

The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2013.

Rutherford 1997

Rutherford RB, Baker JD, Ernst C, Johnston KW, Porter JM, Ahn S, et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. Journal of Vascular Surgery 1997;26(3):517‐38. [PUBMED: 9308598]

Schunemann 2006

Schunemann HJ, Jaeschke R, Cook DJ, Bria WF, El‐Solh AA, Ernst A, et al. An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations. American Journal of Respiratory and Critical Care Medicine 2006;174(5):605‐14. [PUBMED: 16931644]

Slovut 2008

Slovut DP, Sullivan TM. Critical limb ischemia: medical and surgical management. Vascular Medicine 2008;13(3):281‐91.

Sprengers 2010

Sprengers RW, Teraa M, Moll FL, de Wit GA, van der Graaf Y, Verhaar MC. Quality of life in patients with no‐option critical limb ischemia underlines the need for new effective treatment. Journal of Vascular Surgery 2010;52(4):843‐9, 849.e1. [PUBMED: 20598482]

Stoner 2016

Stoner MC, Calligaro KD, Chaer RA, Dietzek AM, Farber A, Guzman RJ, et al. Reporting standards of the Society for Vascular Surgery for endovascular treatment of chronic lower extremity peripheral artery disease. Journal of Vascular Surgery 2016;64(1):e1‐e21. [PUBMED: 27345516]

Tierney 2007

Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time‐to‐event data into meta‐analysis. Trials 2007;8:16. [PUBMED: 17555582]

van Bemmelen 1994

van Bemmelen PS, Mattos MA, Faught WE, Mansour MA, Barkmeier LD, Hodgson KJ, et al. Augmentation of blood flow in limbs with occlusive arterial disease by intermittent calf compression. Journal of Vascular Surgery 1994;19(6):1052‐8.

Zaki 2016

Zaki M, Elsherif M, Tawfick W, El Sharkawy M, Hynes N, Sultan S. The role of sequential pneumatic compression in limb salvage in non‐reconstructable critical limb ischemia. European Journal of Vascular and Endovascular Surgery 2016;51(4):565‐71. [PUBMED: 26876113]
Table 1. Intermittent pneumatic compression compared with medical therapy alone for critical limb ischaemia at 12 months

Intermittent pneumatic compression (IPC) compared with medical therapy alone for critical limb ischaemia (CLI) at 12 months

Patient or population: patients with CLI

Settings: hospital

Intervention: IPCa

Comparison: medical therapyb

Outcomes

Illustrative comparative risks* (95% CI)

Relative effect
(95% CI)

No. of participants
(studies)

Quality of the evidence
(GRADE)

Comments

Assumed risk

Corresponding risk

Medical therapy

IPC

Amputation

12 months

Major adverse limb events (MALE)

12 months

Amputation‐free survival

12 months

Major adverse cardiovascular events (MACE)

12 months

Ulcer healing

12 months

Death

12 months

Health‐related quality of life

12 months

*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval (CI)) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).

CLI: critical limb ischaemia; IPC: Intermittent pneumatic compression; RR: risk ratio.

GRADE Working Group grades of evidence.
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.

aIPC involves sequential inflation and deflation of pneumatic pressure cuffs placed on the patient's limb. An automatic air source is connected to the cuff to allow intermittent inflation of the cuffs to pressures close to systolic pressure, followed by rapid deflation.

bMedical therapy can include any of the following: antiplatelet therapy, lipid‐lowering therapy, antithrombotic therapy, antihypertensive therapy, or smoking cessation therapy.

Figures and Tables -
Table 1. Intermittent pneumatic compression compared with medical therapy alone for critical limb ischaemia at 12 months
Navigate to table in Protocol